WW WW International Inc.

WW Schedules Fourth Quarter and Full Year 2022 Earnings Conference Call

WW Schedules Fourth Quarter and Full Year 2022 Earnings Conference Call

NEW YORK, Feb. 22, 2023 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or “the Company”) will release its results for the fourth quarter and full year 2022 after market close on Monday, March 6, 2023.

WW will host a conference call at 5:00 p.m. ET the same day. During the conference call, Sima Sistani, Chief Executive Officer, and Heather Stark, Interim Principal Financial Officer, will discuss the fourth quarter and full year 2022 results and answer questions from the investment community.

The live webcast of the conference call will be available on the Company’s corporate website, , in the Investors section under Presentations and Events. Supplemental investor materials will also be available in the same location prior to the start of the webcast. A replay of the webcast will be available on this site for approximately 90 days.

About WW International, Inc.

WeightWatchers is a human-centric technology company powered by the world's leading commercial weight management program. For nearly six decades, we have inspired millions of people to adopt healthy habits for real life. Through our comprehensive tools, expert Coaches and community, members follow our proven, sustainable, science-based program focused on weight loss. To learn more about the WeightWatchers approach to healthy living, please visit . For more information about our global business, visit our corporate website at .

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management's current expectations and beliefs, as well as a number of assumptions concerning future events. These statements are subject to risks, uncertainties, assumptions and other important factors. Readers are cautioned not to put undue reliance on such forward-looking statements because actual results may vary materially from those expressed or implied. The reports filed by the Company pursuant to United States securities laws contain discussions of these risks and uncertainties. The Company assumes no obligation to, and expressly disclaims any obligation to, update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Readers are advised to review the Company's filings with the United States Securities and Exchange Commission (which are available on the SEC's EDGAR database at  and via the Company's website at corporate.ww.com).

For more information, contact:

Corey Kinger



EN
22/02/2023

Underlying

WWWW International Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on WW International Inc.

 PRESS RELEASE
Free
WW WW Internationa...

CheqUp and WeightWatchers Announce Strategic Partnership to Support Gr...

CheqUp and WeightWatchers Announce Strategic Partnership to Support Growing Use of GLP-1 Medications in the UK Partnership Provides CheqUp Members Access to WeightWatchers’ Proven GLP-1 Companion Programme to Aid in Achieving Superior and Sustainable Results CHIPPENHAM, England, May 22, 2025 (GLOBE NEWSWIRE) -- , one of the UK’s leading providers of GLP-1 based weight loss services, and , the global leader in science-backed weight management, have announced a partnership that will combine the offerings of both organizations to benefit patients seeking sustainable weight loss through GLP...

May 22, 2025 1 EN
 PRESS RELEASE
Free
WW WW Internationa...

WeightWatchers Takes Strategic Action to Eliminate $1.15 Billion of De...

WeightWatchers Takes Strategic Action to Eliminate $1.15 Billion of Debt, Strengthening Financial Position for Long-Term Growth and Profitability Operations continue with no impact to its more than three million members worldwide Positions the Company to execute its transformation strategy, focused on enhancing its digital and member experience and expanding its telehealth business which achieved 57% year-over-year revenue growth in Q1 2025 Enters comprehensive agreement with lenders and noteholders to significantly reduce its debt obligations and bolster financial flexibility ...

May 6, 2025 1 EN
 PRESS RELEASE
Free
WW WW Internationa...

WW International, Inc. Schedules Investor Conference Call

WW International, Inc. Schedules Investor Conference Call NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers” or the “Company”), the global leader in science-backed weight management, announced that it will host an investor conference call today May 6, 2025, at 6:00 p.m. ET. During the call, Tara Comonte, President and Chief Executive Officer, and Felicia DellaFortuna, Chief Financial Officer, will discuss an agreement with the Company’s lenders and noteholders that will significantly reduce debt obligations that is currently expected to result...

May 6, 2025 1 EN
 PRESS RELEASE
Free
WW WW Internationa...

WW International, Inc. Announces First Quarter 2025 Results

WW International, Inc. Announces First Quarter 2025 Results Total End of Period Subscribers of 3.4 million, including 135 thousand End of Period Clinical SubscribersRevenues of $186.6 million, down 9.7% vs. prior year period, including Clinical Subscription Revenues of $29.5 million, up 57.1% vs. prior year periodSubscription Revenues Per Paid Weeks up 4.8% vs. prior year periodGross Margin of 71.2%, up 450 basis points vs. prior year period; Adjusted Gross Margin of 71.0%, up 311 basis points vs. prior year periodNet Loss of $72.6 million; Net Loss Margin of 38.9%, improved from Net Loss M...

May 6, 2025 1 EN
 PRESS RELEASE
Free
WW WW Internationa...

WeightWatchers Streamlines Member Access to Zepbound® Vials with Lilly...

WeightWatchers Streamlines Member Access to Zepbound® Vials with LillyDirect® Pharmacy Provider New Integration with Gifthealth Simplifies Fulfillment and Medication Visibility for WeightWatchers Clinic Members NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”), the global leader in science-backed weight management, today announced a pharmacy integration with Eli Lilly and Company’s LillyDirect® pharmacy provider, . The integration will streamline access to Lilly’s FDA-approved Zepbound® (tirzepatide) single-dose vials for WeightWatcher...

April 29, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch